MedPath

Shanghai Fudan University Huashan Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Efficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACO

Not Applicable
Conditions
Asthma-COPD Overlap
Interventions
Drug: triple combinations
Drug: double combinations
First Posted Date
2018-04-20
Last Posted Date
2018-04-20
Lead Sponsor
Huashan Hospital
Target Recruit Count
120
Registration Number
NCT03504527

The Therapeutic Time Window of Mannitol During Craniotomy for Optimal Brain Relaxation in Patients With Supratentorial Tumours

Not Applicable
Completed
Conditions
Supratentorial Tumors
Interventions
First Posted Date
2018-02-23
Last Posted Date
2020-11-20
Lead Sponsor
Huashan Hospital
Target Recruit Count
100
Registration Number
NCT03444519
Locations
🇨🇳

Fudan University affiliated Huashan Hospital, Shanghai, Shanghai, China

mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer

Phase 3
Completed
Conditions
Apatinib
Interventions
First Posted Date
2017-12-07
Last Posted Date
2023-02-14
Lead Sponsor
Huashan Hospital
Target Recruit Count
63
Registration Number
NCT03365765
Locations
🇨🇳

Huashan Hospital Affiliated to Fudan University, Shanghai, China

Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme

Early Phase 1
Conditions
Glioblastoma Multiforme
Interventions
Drug: TIL
First Posted Date
2017-11-20
Last Posted Date
2021-08-25
Lead Sponsor
Huashan Hospital
Target Recruit Count
40
Registration Number
NCT03347097
Locations
🇨🇳

Huashan hospital, Fudan University, Shanghai, Shanghai, China

Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD

Not Applicable
Conditions
Acute Exacerbation Copd
Venous Thromboembolism
Interventions
First Posted Date
2017-09-08
Last Posted Date
2017-09-08
Lead Sponsor
Huashan Hospital
Target Recruit Count
438
Registration Number
NCT03277001
Locations
🇨🇳

Huashan hospital,Fudan university, Shanghai, Shanghai, China

Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPD

Not Applicable
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
First Posted Date
2017-08-23
Last Posted Date
2017-10-19
Lead Sponsor
Huashan Hospital
Target Recruit Count
120
Registration Number
NCT03258749
Locations
🇨🇳

Huashan hospital,Fudan university, Shanghai, Shanghai, China

The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection

Phase 4
Conditions
Chronic Hepatitis b
Hepatic Carcinoma
Interventions
Drug: ETV;TDF;ADV
First Posted Date
2017-08-17
Last Posted Date
2017-09-08
Lead Sponsor
Huashan Hospital
Target Recruit Count
432
Registration Number
NCT03253250
Locations
🇨🇳

Huashan Hospital, Shanghai, China

Application of NGS Technique in Precise Diagnosis of Infectious Diseases

Conditions
Infectious Disease
Next Generation Sequencing
First Posted Date
2017-07-27
Last Posted Date
2017-07-27
Lead Sponsor
Huashan Hospital
Target Recruit Count
1500
Registration Number
NCT03232242
Locations
🇨🇳

Huashan Hospital of Fudan University, Shanghai, Shanghai, China

Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder

Conditions
Major Depressive Disorder
Interventions
First Posted Date
2017-07-26
Last Posted Date
2017-07-26
Lead Sponsor
Huashan Hospital
Target Recruit Count
80
Registration Number
NCT03230682
Locations
🇨🇳

Dept. of Neurology, Huashan Hospital, Fudan University, Shanghai, Shanghai, China

the Regulation of Phosphorus Homeostasis by Dietary Phosphorus Intake in Normal Men

Not Applicable
Completed
Conditions
Healthy
Interventions
Other: normal diet
Other: low-phosphorus diet
Other: high-phosphorus diet
First Posted Date
2017-07-05
Last Posted Date
2017-08-15
Lead Sponsor
Huashan Hospital
Target Recruit Count
6
Registration Number
NCT03208075
Locations
🇨🇳

Huashan hospital, Shanghai Medical College, Fudan University, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath